(19)
(11) EP 3 204 876 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.11.2018 Bulletin 2018/48

(45) Mention of the grant of the patent:
24.10.2018 Bulletin 2018/43

(21) Application number: 15771589.7

(22) Date of filing: 29.09.2015
(51) International Patent Classification (IPC): 
A61M 5/20(2006.01)
A61M 15/00(2006.01)
G16H 40/63(2018.01)
G09B 5/06(2006.01)
 A61M 5/315(2006.01)
G06F 19/00(2018.01)
G09B 1/32(2006.01)
G09B 1/14(2006.01)
(86) International application number:
PCT/EP2015/072410
(87) International publication number:
WO 2016/055305 (14.04.2016 Gazette 2016/15)

(54)

MEDICAMENT DELIVERY DEVICE

MEDIKAMENTENVERABREICHUNGSVORRICHTUNG

DISPOSITIFS D'ADMINISTRATION DE MÉDICAMENTS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 06.10.2014 US 201462060276 P
23.02.2015 EP 15156116

(43) Date of publication of application:
16.08.2017 Bulletin 2017/33

(73) Proprietor: SHL Medical AG
6300 Zug (CH)

(72) Inventors:
  • BAUSS, Markus
    84435 Lengdorf (DE)
  • LINDSTEDT, Per
    139 54 Värmdö (SE)
  • RENSTAD, Rasmus
    114 29 Stockholm (SE)
  • HAUTAVIITA, Nikolaj
    197 91 Bro (SE)
  • SÄLL, Daniel
    141 73 Segeltorp (SE)


(56) References cited: : 
US-A1- 2012 326 885
US-A1- 2013 184 649
 US-A1- 2013 181 814
US-A1- 2014 292 493
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).